Skip to main content
. 2020 Mar 9;55(1):30–38. doi: 10.14744/TurkPediatriArs.2019.60938

Table 3.

Drug classes of clinically significant potential drug-drug interactions

Drug class (n) Drug Potential drug for interaction Category of interaction

Drug n
Anti-infective (48) Clarithromycin Budesonide 20 C
Clarithromycin Methylprednisolone 14 D
Clarithromycin Dexamethasone 2 D
Clarithromycin Midazolam 1 D
Ceftriaxone Streptomycin 2 C
Rifampicin Isoniazid 1 C
Rifampicin Valproic acid 1 D
Isoniazid Valproic acid 1 C
Ceftriaxone Gentamicin 1 C
Ceftriaxone Amikacin 1 C
Cefepime Amikacin 1 C
Streptomycin Ibuprofen 1 C
Meropenem Valproic acid 1 D
Vancomycin Colistin 1 D
Central nervous system (13) Phenobarbital Levetiracetam 5 C
Phenobarbital Midazolam 2 D
Phenytoin Midazolam 1 D
Fentanyl Sertraline 1 C
Fentanyl Pheniramine 1 D
Diazepam Levetiracetam 1 C
Midazolam Levetiracetam 1 C
Clonazepam Levetirecetam 1 C
Endocrine system (7) Methylprednisolone Ibuprofen 3 C
Budesonid Furosemide 3 C
Prednisolon Furosemide 1 C
Cardiovascular system (4) Furosemide Enalapril 2 C
Furosemide Digoxin 1 C
Furosemide Captopril 1 C
Gastrointestinal system (3) Aluminium hydroxide and
magnesium carbonate antacid Amikacin 1 C
Aluminium hydroxide and
magnesium carbonate antacid Prednisolone 1 D
Aluminium hydroxide and
magnesium carbonate antacid Ursodeoxycholic acid 1 D
Respiratory system (2) Salbutamol Furosemide 2 C
Nonsteroidal anti-inflammatory drugs (2) Acetylsalicylic acid Enalapril 1 C
Ibuprofen Vancomycin 1 C